Director J Singleton Sells 20,786 Shares of Viking Therapeutics Inc (VKTX)

Investing19:13 ET

Deutsche Bank praises Eli Lilly and Co (LLY.US) as a "high-growth unicorn", with a target price skyrocketing to $1025.

Deutsche Bank has upgraded its rating on Eli Lilly and Co (LLY.US) from "hold" to "buy" with a target price increase from $725 to $1025.

Zhitong FinanceAug 13 02:52 ET

Buy Russell 1000 Health Care Growth, Says Oppenheimer in Highlighting Top Sector Ideas

Seeking AlphaAug 12 13:48 ET

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaAug 12 13:35 ET

Buy Rating on Viking Therapeutics: Promising VK2735 Development and Strategic Advancements

TipRanksAug 12 09:11 ET · Ratings

What Eli Lilly, Novo Nordisk Earnings Reveal About the Future of GLP-1 Sales

Yahoo FinanceAug 11 08:09 ET